Emerson Electric Co.

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +50

Emerson's Intelligent Devices Segment Gains Momentum: Can It Sustain?

AI-generated analysis

πŸ“ˆ Emerson's Intelligent Devices segment sales rose 2% year-over-year to $1.49 billion in the second quarter of fiscal 2026.

⚑ Final Control business strength is supported by robust demand in power and LNG end markets.

🌎 Robust growth across the Americas region drove a 2% year-over-year increase in Emerson's Sensors business sales to $1.02 billion.

⚠️ Softness in Europe and China, along with geopolitical tensions in the Middle East, remains a concern for Emerson's Sensors business.

πŸ’» The Software and Systems segment is positioned to benefit from growth in its AspenTech unit and strength in Test & Measurement businesses.

πŸ“ˆ Given strength across most businesses, Emerson expects net sales to increase approximately 4.5% year-over-year in fiscal 2026.

πŸ“‰ Underlying sales are anticipated to grow about 3% year-over-year in fiscal 2026 (ended September 2026).

🀝 Peer Ingersoll Rand Inc. saw its Industrial Technologies & Services segment revenues rise 6.8% year-over-year to $1.45 billion.

βš™οΈ Ingersoll Rand's growth was driven by strong orders across industrial vacuums, blowers, and compressors.

πŸ“‰ Peer Flowserve Corp. experienced a 4.9% year-over-year decline in revenues for its Pump Division segment to $744.5 million.

🏭 Flowserve's decline was affected by lower capital spending by customers and delays in large project awards.

πŸ“Š Emerson shares gained 2.7% in the past three months compared with the industry's growth of 14.7%.

πŸ’° From a valuation standpoint, EMR is trading at a forward P/E ratio of 20.51X, below the industry average of 24.72X.

πŸ“‰ Emerson carries a Value Score of D and a Zacks Rank #3 (Hold).

πŸ“‰ The Zacks Consensus Estimate for EMR's fiscal 2026 earnings has inched down 0.2% over the past 60 days.

Bullish Signals
  • Emerson's Intelligent Devices segment demonstrated solid momentum with Final Control business sales increasing 2% year over year to $1.49 billion in the second quarter of fiscal 2026.
  • Robust growth across the Americas region drove Emerson's Sensors business, which saw sales rise 2% year over year to $1.02 billion in the same period.
  • Emerson expects net sales to increase approximately 4.5% year over year in fiscal 2026, supported by strength in its Software and Systems segment including the AspenTech unit.
  • Underlying sales are anticipated to grow about 3% year over year in fiscal 2026, indicating organic business expansion.
  • Emerson shares have gained 2.7% in the past three months, outperforming the industry average growth of 14.7% on a relative basis while trading at a forward P/E ratio of 20.51X below the industry average of 24.72X.
Risk Factors
  • Softness in Europe and China, attributed to a tepid demand environment and geopolitical tensions in the Middle East, remains a concern for Emerson's growth trajectory.
  • The Zacks Consensus Estimate for EMR's fiscal 2026 earnings has decreased slightly by 0.2% over the past 60 days.
  • EMR shares have gained only 2.7% over the past three months compared with an industry growth of 14.7%, indicating underperformance relative to peers.
Full Analysis
Emerson Electric Co. (EMR) is experiencing solid momentum within its Intelligent Devices segment, driven by strong demand in the power and LNG end markets. Specifically, the Final Control business saw sales increase 2% year over year to $1.49 billion in the second quarter of fiscal 2026, which ended in March 2026. This growth is further supported by robust performance across the Americas region for the Sensors business, where revenues rose 2% year over year to $1.02 billion. The company's Software and Systems segment is also well-positioned due to solid growth in its AspenTech unit and strength in Test & Measurement and Control Systems & Software businesses. Given this broad-based strength across most of its operations, Emerson expects net sales to increase approximately 4.5% year over year for fiscal 2026, which concludes in September 2026. Underlying sales are anticipated to grow about 3% year over year during the same period. However, there are regional concerns that could impact future performance. Softness in Europe and China, attributed to a tepid demand environment and geopolitical tensions in the Middle East, remains a concern for the company's growth trajectory. In terms of valuation, EMR shares have gained 2.7% over the past three months compared with an industry growth of 14.7%, and the stock trades at a forward price-to-earnings ratio of 20.51X, which is below the industry average of 24.72X. The Zacks Consensus Estimate for EMR's fiscal 2026 earnings has decreased slightly by 0.2% over the past 60 days, and the stock currently carries a Zacks Rank #3 (Hold).